Skip to main content
Novartis
language-selector-globe
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español(link is external)
Brazil | Português(link is external)
Canada | English(link is external)
Canada | Français(link is external)
Central America | Español(link is external)
Colombia | Español(link is external)
Mexico | Español(link is external)
United States | English(link is external)
Australia | English(link is external)
Bangladesh | English(link is external)
Hong Kong S.A.R. | 繁體中文(link is external)
India | English(link is external)
Indonesia | English(link is external)
Japan | 日本語(link is external)
Korea | 한국어(link is external)
Mainland China | 中文(link is external)
Malaysia | English(link is external)
Pakistan | English(link is external)
Philippines | English
Singapore | English(link is external)
Taiwan | 繁體中文(link is external)
Thailand | ภาษาไทย(link is external)
Austria | Deutsch(link is external)
Belgium | Français(link is external)
Belgium | Nederlands(link is external)
Bulgaria | Български(link is external)
Czech Republic | Česky(link is external)
Czech Republic | English(link is external)
Denmark | Dansk(link is external)
Estonia | Eesti(link is external)
Finland | Suomalainen(link is external)
France | Français(link is external)
Germany | Deutsch(link is external)
Greece | Ελληνικά(link is external)
Hungary | Magyar(link is external)
Ireland | English(link is external)
Italy | Italiano(link is external)
Latvia | Latvian(link is external)
Lithuania | Lithuanian(link is external)
Netherlands | Nederlands(link is external)
Norway | Norsk(link is external)
Poland | Polski(link is external)
Portugal | Português(link is external)
Romania | Română(link is external)
Russia | Русский(link is external)
Serbia | Srpski(link is external)
Slovakia | Slovensky(link is external)
Slovenia | Slovenščina(link is external)
Slovenia | English(link is external)
Spain | Español(link is external)
Sweden | Svenska(link is external)
Switzerland | Deutsch(link is external)
Switzerland | Français(link is external)
Türkiye | Türkçe(link is external)
United Kingdom | English(link is external)
Global | English(link is external)
Novartis Foundation | English(link is external)
Egypt | English(link is external)
Israel | עברית(link is external)
Saudi Arabia | العربية(link is external)
South Africa | English(link is external)
language-selector-globe
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español(link is external)
Australia | English(link is external)
Austria | Deutsch(link is external)
Bangladesh | English(link is external)
Belgium | Français(link is external)
Belgium | Nederlands(link is external)
Brazil | Português(link is external)
Bulgaria | Български(link is external)
Canada | English(link is external)
Canada | Français(link is external)
Central America | Español(link is external)
Colombia | Español(link is external)
Czech Republic | Česky(link is external)
Czech Republic | English(link is external)
Denmark | Dansk(link is external)
Egypt | English(link is external)
Estonia | Eesti(link is external)
Finland | Suomalainen(link is external)
France | Français(link is external)
Germany | Deutsch(link is external)
Greece | Ελληνικά(link is external)
Hong Kong S.A.R. | 繁體中文(link is external)
Hungary | Magyar(link is external)
India | English(link is external)
Indonesia | English(link is external)
Ireland | English(link is external)
Israel | עברית(link is external)
Italy | Italiano(link is external)
Japan | 日本語(link is external)
Korea | 한국어(link is external)
Latvia | Latvian(link is external)
Lithuania | Lithuanian(link is external)
Mainland China | 中文(link is external)
Malaysia | English(link is external)
Mexico | Español(link is external)
Netherlands | Nederlands(link is external)
Norway | Norsk(link is external)
Global | English(link is external)
Novartis Foundation | English(link is external)
Pakistan | English(link is external)
Philippines | English
Poland | Polski(link is external)
Portugal | Português(link is external)
Romania | Română(link is external)
Russia | Русский(link is external)
Saudi Arabia | العربية(link is external)
Serbia | Srpski(link is external)
Singapore | English(link is external)
Slovakia | Slovensky(link is external)
Slovenia | Slovenščina(link is external)
Slovenia | English(link is external)
South Africa | English(link is external)
Spain | Español(link is external)
Sweden | Svenska(link is external)
Switzerland | Deutsch(link is external)
Switzerland | Français(link is external)
Taiwan | 繁體中文(link is external)
Thailand | ภาษาไทย(link is external)
Türkiye | Türkçe(link is external)
United Kingdom | English(link is external)
United States | English(link is external)
    • About 

      • Novartis in Philippines 
      • Strategy  (link is external)
      • Diversity and Inclusion  (link is external)
      • People and Culture  (link is external)
      • Products  (link is external)
      • Country Leadership Team 
      • Contact 
      Novartis Philippines About
      About
    • Patients and Caregivers 

      • Novartis Commitment to Patients and Caregivers 
      • Diseases  (link is external)
      • Patient resources 
      • Products  (link is external)
      • Adverse Event Reporting  (link is external)
      Patients and Caregivers
      Patients and Caregivers
    • Healthcare Professionals 

      • Healthcare professional country resource  (link is external)
      • Products  (link is external)
      • Novartis Pipeline  (link is external)
      • Adverse Event Reporting  (link is external)
      • Novartis Clinical Trials  (link is external)
      Scientist in a lab
      Healthcare Professionals
    • ESG 

      • Financial Transparency for Philippines 
      • Ethical Behavior 

        • Code of Ethics 
        • SpeakUp 
      • Ethics, Risk and Compliance  (link is external)
      • Access  (link is external)
      • Environmental Sustainability  (link is external)
      • Global Health  (link is external)
      ESG
      ESG
    • News 

      • News Archive 
      • Stories 
      • Contacts 
      Business people, talking in a meeting room
      News
    • Careers 

      • Career Search 
      • Meet the teams  (link is external)
      • Early Talent  (link is external)
      • How We Work  (link is external)
      • Diversity and Inclusion  (link is external)
      • Career Programs  (link is external)
      • Awards and Recognition  (link is external)
      Careers
      Careers
    • Coronavirus 

      Coronavirus under the microscope
      Coronavirus
    Home Novartis Philippines
    Home

Breast Cancer

Multimedia materials to help you better understand breast cancer. Learning more about the disease will help us realize how important it is to seek treatment and talk to your oncologist. Breast cancer patients need our support more than ever.
What is PIK3CA and why is it important to you?

What is PIK3CA and why is it important to you?

A leaflet informing about the PIK3CA mutation and why does it occur in breast cancer.

Tuklasin ang Lihim sa Likod ng Kanser sa Suso

Tuklasin ang Lihim sa Likod ng Kanser sa Suso

May iba’t ibang uri ng kanser sa suso. Tuklasin kung bakit may mga pasyenteng nangangailangan ng makabagong gamutan sa infographic na ito.

See What Lies Beneath Breast Cancer

See What Lies Beneath Breast Cancer

There are different types of breast cancer. Get to know why patients have varying treatment needs in this infographic.

Ano ang PIK3CA gene mutations?

Hindi Pare-pareho ang mga uri ng kanser sa suso

May iba’t ibang uri ng kanser sa suso. Tuklasin kung bakit may mga pasyenteng nangangailangan ng makabagong gamutan sa infographic na ito.

See What Lies Beneath Breast Cancer

See What Lies Beneath Breast Cancer - Video

Breast Cancer patients need the support of loved ones.

beyond-the-pink-ribbon

2024 PNCS Novartis Symposium

Beyond the Pink Ribbon: Empowering Patients to Navigate the Healthcare Maze for Better Breast Cancer Survivorship

Improving Breast Cancer Survivorship in the Philippines: Policy and Program Implications from The Pink Initiative

Improving Breast Cancer Survivorship in the Philippines: Policy and Program Implications from The Pink Initiative

The Pink Initiative roundtable series, a concerted effort to address breast cancer in the Philippines, convened key stakeholders to strategize improving patient outcomes

AddToAny buttons

ShareTweetShareWhatsappLinkedinEmail

Printable Links Block (Content)

  • Print
  • Save

Novartis Philippines

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • News Archive
  • Stories
Our Portfolio
  • Novartis Clinical Pipeline(link is external)
  • Novartis Product Portfolio(link is external)
NPC Seal of Registration
  • (link is external)
  • (link is external)
  • (link is external)
  • (link is external)
  • (link is external)
Footer Bottom
© 2025 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility(link is external)
Novartis Site Directory (link is external)
This site is intended for an audience in the Philippines